BLS 0602
Latest Information Update: 04 Jun 2002
At a glance
- Originator Boston Life Sciences
- Class Antiparkinsonians; Neuroprotectants
- Mechanism of Action Dopamine plasma membrane transport protein antagonists; Dopamine uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Parkinson's disease